Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-β peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease

Medicine & Life Sciences

• BAY 73-6691 100%
• Phosphodiesterase Inhibitors 54%
• Amyloid 42%
• Alzheimer Disease 34%
• Oxidative Stress 32%
• Peptides 28%
• In Vitro Techniques 19%
• Memory 12%
• Neurons 6%
• Maze Learning 6%
• Spatial Memory 6%
• Intraperitoneal Injections 5%
• Free Radicals 5%
• Hippocampus 4%
• Antioxidants 4%
• Learning 4%
• Pharmacology 3%
• Therapeutics 3%
• Injections 3%
• Proteins 2%